Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci.

Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, Cuerdon NE, Ryan KJ, Johnson KA, Schneider JA, Bennett DA, Chibnik LB, Sperling RA, De Jager PL, Bradshaw EM.

Neurol Genet. 2016 Jul 26;2(4):e90. doi: 10.1212/NXG.0000000000000090. eCollection 2016 Aug.

2.

The single nucleotide polymorphism Rs12817488 is associated with Parkinson's disease in the Chinese population.

Yu RL, Guo JF, Wang YQ, Liu ZH, Sun ZF, Su L, Zhang Y, Yan XX, Tang BS.

J Clin Neurosci. 2015 Jun;22(6):1002-4. doi: 10.1016/j.jocn.2014.11.024. Epub 2015 Mar 26.

PMID:
25818163
3.

Association analysis of STK39, MCCC1/LAMP3 and sporadic PD in the Chinese Han population.

Wang YQ, Tang BS, Yu RL, Li K, Liu ZH, Xu Q, Sun QY, Yan XX, Guo JF.

Neurosci Lett. 2014 Apr 30;566:206-9. doi: 10.1016/j.neulet.2014.03.007. Epub 2014 Mar 12.

PMID:
24631562
4.

GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16.

Soto-Ortolaza AI, Heckman MG, Labbé C, Serie DJ, Puschmann A, Rayaprolu S, Strongosky A, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Lynch T, Uitti RJ, Wszolek ZK, Ross OA.

Am J Neurodegener Dis. 2013 Nov 29;2(4):287-99. eCollection 2013.

5.

Genetic association study between STK39 and CCDC62/HIP1R and Parkinson's disease.

Li NN, Tan EK, Chang XL, Mao XY, Zhang JH, Zhao DM, Liao Q, Yu WJ, Peng R.

PLoS One. 2013 Nov 27;8(11):e79211. doi: 10.1371/journal.pone.0079211. eCollection 2013.

6.

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.

Pihlstrøm L, Axelsson G, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Ohman E, Dietrichs E, Toft M.

Neurobiol Aging. 2013 Jun;34(6):1708.e7-13. doi: 10.1016/j.neurobiolaging.2012.10.019. Epub 2012 Nov 13.

PMID:
23153929
7.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium.

Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11.

8.

Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease.

Lauterbach EC.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):107-15. doi: 10.1016/j.pnpbp.2012.03.011. Epub 2012 Apr 3. Review.

PMID:
22507762
9.

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.

Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, DeStefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP; 23andMe Genetic Epidemiology of Parkinson's Disease Consortium; International Parkinson's Disease Genomics Consortium; Parkinson's Disease GWAS Consortium; Wellcome Trust Case Control Consortium 2), Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JP, Bertram L.

PLoS Genet. 2012;8(3):e1002548. doi: 10.1371/journal.pgen.1002548. Epub 2012 Mar 15.

10.

The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

Lauterbach EC, Fontenelle LF, Teixeira AL.

Parkinsons Dis. 2012;2012:753548. doi: 10.1155/2012/753548. Epub 2011 Dec 27.

11.

Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.

Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, Lee JH.

BMC Med Genet. 2011 Aug 3;12:104. doi: 10.1186/1471-2350-12-104.

12.

Genetics of Parkinson's disease and essential tremor.

Zimprich A.

Curr Opin Neurol. 2011 Aug;24(4):318-23. doi: 10.1097/WCO.0b013e3283484b87. Review.

PMID:
21734494
13.

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simón-Sánchez J, Schulte C, Lesage S, Sveinbjörnsdóttir S, Stefánsson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW.

Lancet. 2011 Feb 19;377(9766):641-9. doi: 10.1016/S0140-6736(10)62345-8. Epub 2011 Feb 1.

Supplemental Content

Loading ...
Support Center